Is Armata Pharmaceuticals Inc (ARMP) overvalued? · $70.2M cap
Armata Pharmaceuticals Inc (ARMP) is a biotechnology company listed on US.
This page asks whether Armata Pharmaceuticals Inc (ARMP) looks expensive on cached numbers — not a short thesis.
No cached income statement for ARMP, so there is no earnings base to call rich or cheap.
ARMP currently screens at market cap $70.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ARMP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ARMP stock page for the full model, not this heading.
Not investment advice.